We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
-16.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
–
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
110.29%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
443
New
443
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$63.6M |
| 2 |
Microsoft
MSFT
|
+$62.3M |
| 3 |
CELG
Celgene Corp
CELG
|
+$52.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$37.9M |
| 5 |
Agios Pharmaceuticals
AGIO
|
+$34.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.3% |
| 2 | Technology | 21.29% |
| 3 | Consumer Discretionary | 12.85% |
| 4 | Financials | 8.82% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$448B
| $13.5M | 0.91% |
+314,589
| New | +$14.4M |
|
27
Intel
INTC
$460B
| $12.8M | 0.86% |
+276,137
| New | +$12.9M |
|
28
Mastercard
MA
$510B
| $11.1M | 0.75% |
+58,970
| New | +$11.7M |
|
29
Thermo Fisher Scientific
TMO
$214B
| $10.6M | 0.71% |
+47,780
| New | +$11.2M |
|
30
Intuit
INTU
$86.3B
| $10.1M | 0.68% |
+51,382
| New | +$10.7M |
|
31
Home Depot
HD
$332B
| $9.89M | 0.66% |
+58,245
| New | +$10.4M |
|
32
Gilead Sciences
GILD
$163B
| $9.54M | 0.64% |
+151,640
| New | +$10.6M |
|
33
Texas Instruments
TXN
$255B
| $9.52M | 0.64% |
+101,698
| New | +$9.84M |
|
34
UnitedHealth
UNH
$383B
| $9.47M | 0.64% |
+38,630
| New | +$10.2M |
|
35
Regeneron Pharmaceuticals
REGN
$77.4B
| $9.45M | 0.63% |
+25,900
| New | +$9.48M |
|
36
PepsiCo
PEP
$191B
| $9.24M | 0.62% |
+84,435
| New | +$9.52M |
|
37
Alphabet (Google) Class C
GOOG
$4.08T
| $8.95M | 0.6% |
+171,440
| New | +$9.18M |
|
|
ATVI
38
DELISTED
Activision Blizzard
ATVI
| $8.72M | 0.59% |
+185,580
| New | +$11.1M |
|
39
Neurocrine Biosciences
NBIX
$18.7B
| $8.44M | 0.57% |
+120,900
| New | +$11.6M |
|
40
Sherwin-Williams
SHW
$83.7B
| $8.28M | 0.56% |
+63,600
| New | +$8.58M |
|
41
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $8.24M | 0.55% |
+33,270
| New | +$8.97M |
|
42
Procter & Gamble
PG
$335B
| $7.83M | 0.53% |
+85,070
| New | +$7.6M |
|
43
Amphenol
APH
$197B
| $7.75M | 0.52% |
+385,360
| New | +$8.28M |
|
44
Valero Energy
VLO
$92.6B
| $7.72M | 0.52% |
+103,900
| New | +$9.13M |
|
45
PayPal
PYPL
$49.3B
| $7.56M | 0.51% |
+90,040
| New | +$7.5M |
|
46
Alibaba
BABA
$279B
| $7.36M | 0.49% |
+53,185
| New | +$7.86M |
|
47
Constellation Brands
STZ
$22.3B
| $6.99M | 0.47% |
+42,830
| New | +$8.51M |
|
|
ALXN
48
DELISTED
Alexion Pharmaceuticals
ALXN
| $6.88M | 0.46% |
+70,150
| New | +$8.29M |
|
49
Union Pacific
UNP
$172B
| $6.82M | 0.46% |
+49,730
| New | +$7.37M |
|
50
iShares Core S&P 500 ETF
IVV
$872B
| $6.61M | 0.44% |
+26,510
| New | +$7.2M |
|
Similar funds
AIM
TRSOTSOK
GC
CII
AAMU
NMIFOAC
WANY
Erste Asset Management's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Erste Asset Management, which disclosed 443 positions worth $1.49B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Sarepta Therapeutics: 508,810 shares worth $54.8M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Technology and Consumer Discretionary.
- Erste Asset Management's largest Q4 2018 buy was Sarepta Therapeutics: 508,810 shares worth $54.8M.
- Erste Asset Management's ten largest holdings make up 25% of its $1.49B portfolio in Q4 2018.
- Erste Asset Management disclosed 443 positions in Q4 2018, its first 13F filing on record.
Based on Erste Asset Management's 13F filing for Q4 2018, filed 26 Nov 2024.